Mascard E, Gaspar N, Brugières L, Glorion C, Pannier S, Gomez-Brouchet A
Necker University Hospital, 75015 Paris, France.
Department of Pediatrics, Institute Gustave Roussy, 94805 Villejuif, France.
EFORT Open Rev. 2017 May 11;2(5):261-271. doi: 10.1302/2058-5241.2.160078. eCollection 2017 May.
Most of tumours of the foot are tumour-like (synovial cyst, foreign body reactions and epidermal inclusion cyst) or benign conditions (tenosynovial giant cells tumours, planta fibromatosis). Malignant tumours of the soft-tissue and skeleton are very rare in the foot and their diagnosis is often delayed with referral to specialised teams after initial inappropriate procedures or unplanned excisions. The adverse effect of these misdiagnosed tumours is the increasing rate of amputation or local recurrences in the involved patients. In every lump, imaging should be discussed before any local treatment. Every lesion which is not an obvious synovial cyst or plantar fibromatosis should have a biopsy performed.After the age of 40 years, chondrosarcoma is the most usual malignant tumour of the foot. In young patients bone tumours such as osteosarcoma or Ewing's sarcoma, are very unusually located in the foot. Synovial sarcoma is the most frequent histological diagnosis in soft tissues. Epithelioid sarcoma or clear cell sarcoma, involve more frequently the foot and ankle than other sites. The classic local treatment of malignant conditions of the foot and ankle was below-knee amputation at different levels. Nowadays, with the development of adjuvant therapies, some patients may benefit from conservative surgery or partial amputation after multidisciplinary team discussions.The prognosis of foot malignancy is not different from that at other locations, except perhaps in chondrosarcoma, which seems to be less aggressive in the foot. The anatomy of the foot is very complex with many bony and soft tissue structures in a relatively small space making large resections and conservative treatments difficult to achieve. Cite this article: 2017;2. DOI: 10.1302/2058-5241.2.160078. Originally published online at www.efortopenreviews.org.
足部的大多数肿瘤属于肿瘤样病变(滑膜囊肿、异物反应和表皮样囊肿)或良性疾病(腱鞘巨细胞瘤、跖纤维瘤病)。足部软组织和骨骼的恶性肿瘤非常罕见,其诊断往往因最初的不恰当操作或计划外切除后转诊至专科团队而延迟。这些误诊肿瘤的不良影响是相关患者的截肢率或局部复发率不断上升。对于每个肿块,在进行任何局部治疗之前都应讨论影像学检查。每个并非明显滑膜囊肿或跖纤维瘤病的病变都应进行活检。40岁以后,软骨肉瘤是足部最常见的恶性肿瘤。在年轻患者中,骨肉瘤或尤因肉瘤等骨肿瘤很少发生在足部。滑膜肉瘤是软组织中最常见的组织学诊断类型。上皮样肉瘤或透明细胞肉瘤在足部和踝关节的累及比其他部位更频繁。足部和踝关节恶性疾病的经典局部治疗方法是在不同水平进行膝下截肢。如今,随着辅助治疗的发展,一些患者在多学科团队讨论后可能受益于保守手术或部分截肢。足部恶性肿瘤的预后与其他部位并无不同,软骨肉瘤可能除外,它在足部似乎侵袭性较小。足部的解剖结构非常复杂,在相对较小的空间内有许多骨骼和软组织结构,使得大的切除和保守治疗难以实现。引用本文:2017;2。DOI:10.1302/2058 - 5241.2.160078。最初在线发表于www.efortopenreviews.org。